Brainard Diana

Chief Executive Officer at Kalaris Therapeutics, Inc. · on record since May 18, 2021
Director at Kalaris Therapeutics, Inc. · on record since Jul 31, 2020
Director at NEKTAR THERAPEUTICS · on record since Nov 15, 2021

Insider trading activity of Brainard Diana

Transactions on record: 55; since Jul 31, 2020

Open-market buys: 1; $107.1K

Open-market sells: 34; $676.4K

Companies traded: 2; last filing Sep 25, 2026

Figures computed from official regulatory filings — .

Companies where Brainard Diana has traded

NEKTAR THERAPEUTICS9 tx · Sep 25, 2026
Kalaris Therapeutics, Inc.46 tx · $783.5K · Nov 20, 2024

Track record of Brainard Diana

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Brainard Diana

Co-insiders of Brainard Diana

ADAMIS ANTHONY PKalaris Therapeutics, Inc.
Adams Derek N.Kalaris Therapeutics, Inc.
Ajer Jeffrey RobertNEKTAR THERAPEUTICS
AKKARAJU SRINIVASKalaris Therapeutics, Inc.
Atillasoy ErcemKalaris Therapeutics, Inc.
BANSAL AJAYNEKTAR THERAPEUTICS
Bayko Liisa AnnKalaris Therapeutics, Inc.
Bornstein Jeffrey SKalaris Therapeutics, Inc.
Brenner MalcolmKalaris Therapeutics, Inc.
BROWN MICHAEL A/CANEKTAR THERAPEUTICS
CHESS ROBERTNEKTAR THERAPEUTICS
CHOWRIRA BHARAT MNEKTAR THERAPEUTICS
Curet MyriamNEKTAR THERAPEUTICS
Deep Track Biotechnology Master Fund, Ltd.NEKTAR THERAPEUTICS
Deep Track Capital, LPNEKTAR THERAPEUTICS
Doberstein Stephen KNEKTAR THERAPEUTICS
DRAPEAU LOUISNEKTAR THERAPEUTICS
Dybbs MichaelKalaris Therapeutics, Inc.
EASTHAM KARINNEKTAR THERAPEUTICS
Elam Nevan CNEKTAR THERAPEUTICS
ElevateBio, LLCKalaris Therapeutics, Inc.
F2 Bioscience AV 2022 LLCKalaris Therapeutics, Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
NEKTAR THERAPEUTICSListing on record	Sep 25, 2026	AwardD (derivative)	4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NEKTAR THERAPEUTICSListing on record	Sep 25, 2026	Award	2,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NEKTAR THERAPEUTICSListing on record	Oct 1, 2025	AwardD (derivative)	8,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NEKTAR THERAPEUTICSListing on record	Jan 17, 2025	AwardD (derivative)	120,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Kalaris Therapeutics, Inc.Listing unverified	Nov 20, 2024	Sell	-8,706	0.55 USD	$4.8K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Nov 6, 2024	Sell	-10,609	0.86 USD	$9.1K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Oct 23, 2024	Sell	-9,752	0.78 USD	$7.6K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Oct 4, 2024	Sell	-1,493	0.81 USD	$1.2K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Aug 22, 2024	Sell	-5,390	0.74 USD	$4K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Aug 20, 2024	Sell	-3,091	0.76 USD	$2.3K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Aug 7, 2024	Sell	-10,847	0.73 USD	$7.9K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Jul 23, 2024	Sell	-9,731	0.75 USD	$7.3K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Jul 3, 2024	Sell	-1,489	0.72 USD	$1.1K	SEC
Kalaris Therapeutics, Inc.Listing unverified	May 23, 2024	Sell	-5,149	0.79 USD	$4.1K	SEC
Kalaris Therapeutics, Inc.Listing unverified	May 21, 2024	Sell	-3,075	0.75 USD	$2.3K	SEC
Kalaris Therapeutics, Inc.Listing unverified	May 7, 2024	Sell	-10,240	0.80 USD	$8.2K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Apr 23, 2024	Sell	-9,601	0.75 USD	$7.2K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Apr 4, 2024	Sell	-1,533	0.77 USD	$1.2K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Feb 22, 2024	Sell	-3,097	0.70 USD	$2.2K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Feb 22, 2024	Sell	-5,155	0.71 USD	$3.7K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Feb 6, 2024	Sell	-41,421	0.67 USD	$27.8K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Jan 25, 2024	Sell	-9,500	0.67 USD	$6.4K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Jan 8, 2024	Sell	-1,664	0.64 USD	$1.1K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Nov 21, 2023	Sell	-4,382	1.69 USD	$7.4K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Nov 21, 2023	Sell	-2,689	1.63 USD	$4.4K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
NEKTAR THERAPEUTICSListing on record	Sep 25, 2026	AwardD (derivative)	4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NEKTAR THERAPEUTICSListing on record	Sep 25, 2026	Award	2,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NEKTAR THERAPEUTICSListing on record	Oct 1, 2025	AwardD (derivative)	8,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NEKTAR THERAPEUTICSListing on record	Jan 17, 2025	AwardD (derivative)	120,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Kalaris Therapeutics, Inc.Listing unverified	Nov 20, 2024	Sell	-8,706	0.55 USD	$4.8K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Nov 6, 2024	Sell	-10,609	0.86 USD	$9.1K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Oct 23, 2024	Sell	-9,752	0.78 USD	$7.6K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Oct 4, 2024	Sell	-1,493	0.81 USD	$1.2K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Aug 22, 2024	Sell	-5,390	0.74 USD	$4K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Aug 20, 2024	Sell	-3,091	0.76 USD	$2.3K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Aug 7, 2024	Sell	-10,847	0.73 USD	$7.9K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Jul 23, 2024	Sell	-9,731	0.75 USD	$7.3K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Jul 3, 2024	Sell	-1,489	0.72 USD	$1.1K	SEC
Kalaris Therapeutics, Inc.Listing unverified	May 23, 2024	Sell	-5,149	0.79 USD	$4.1K	SEC
Kalaris Therapeutics, Inc.Listing unverified	May 21, 2024	Sell	-3,075	0.75 USD	$2.3K	SEC
Kalaris Therapeutics, Inc.Listing unverified	May 7, 2024	Sell	-10,240	0.80 USD	$8.2K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Apr 23, 2024	Sell	-9,601	0.75 USD	$7.2K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Apr 4, 2024	Sell	-1,533	0.77 USD	$1.2K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Feb 22, 2024	Sell	-3,097	0.70 USD	$2.2K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Feb 22, 2024	Sell	-5,155	0.71 USD	$3.7K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Feb 6, 2024	Sell	-41,421	0.67 USD	$27.8K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Jan 25, 2024	Sell	-9,500	0.67 USD	$6.4K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Jan 8, 2024	Sell	-1,664	0.64 USD	$1.1K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Nov 21, 2023	Sell	-4,382	1.69 USD	$7.4K	SEC
Kalaris Therapeutics, Inc.Listing unverified	Nov 21, 2023	Sell	-2,689	1.63 USD	$4.4K	SEC